BAVA Bavarian Nordic A/S

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.

The transactions concern the vesting of restricted stock units (RSUs) by members of the Board of Directors and the Executive Management of Bavarian Nordic A/S. For members of the Board of Directors, the RSU’s were awarded as part of their remuneration for 2022, and in accordance with the decision by the Annual General Meeting on April 5, 2022. The transaction reported for President & CEO, Paul Chaplin concerns the vesting of RSUs awarded in 2022 as part of a retention scheme established in 2021, and the transaction for Chief Operating Officer, Russell Thirsk concerns the vesting of RSUs awarded in 2022 as part of a sign-on bonus. The three-year vesting period for the RSUs has now expired, and all conditions for release of the shares have been met.

1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameAnne Louise Eberhard
2.Reason for the notification
a)Position/status



 
Deputy chair of the Board of Bavarian Nordic A/S
b)Initial notification/Amendment Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name Bavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 152.58983
d)Aggregated information
  • Aggregated volume
  • Price
 



983

DKK 150,000.00
e)Date of the transaction 2025-05-09
f)Place of the transaction Outside a trading venue



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameFrank Verwiel
2.Reason for the notification
a)Position/status



 
Member of the Board of Bavarian Nordic A/S
b)Initial notification/Amendment Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name Bavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 152.58983
d)Aggregated information
  • Aggregated volume
  • Price
 



983

DKK 150,000.00
e)Date of the transaction 2025-05-09
f)Place of the transaction Outside a trading venue



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameAnja Gjøl
2.Reason for the notification
a)Position/status



 
Member of the Board of Bavarian Nordic A/S
b)Initial notification/Amendment Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name Bavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 152.58983
d)Aggregated information
  • Aggregated volume
  • Price
 



983

DKK 150,000.00
e)Date of the transaction 2025-05-09
f)Place of the transaction Outside a trading venue



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NamePaul Chaplin
2.Reason for the notification
a)Position/status



 
President and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/Amendment Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name Bavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 155.8125,663
d)Aggregated information
  • Aggregated volume
  • Price
 



25,663

DKK 3,998,552.03
e)Date of the transaction 2025-05-09
f)Place of the transaction Outside a trading venue



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameRussell Thirsk
2.Reason for the notification
a)Position/status



 
Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S
b)Initial notification/Amendment Initial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name Bavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b)Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 110.216,669
d)Aggregated information
  • Aggregated volume
  • Price
 



6,669

DKK 735,000.00
e)Date of the transaction 2025-05-09
f)Place of the transaction Outside a trading venue

About Bavarian Nordic

Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit

Contact investors:

Europe: Rolf Sass Sørensen, Vice President Investor Relations, , Tel:

US: Graham Morrell, Paddock Circle Advisors, , Tel:

Contact media:

Nicole Seroff, Vice President Corporate Communications, , Tel:

Company Announcement no. 17 / 2025

Attachment



EN
09/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Indberetning af ledende medarbejdere og disses nærtståendes transaktio...

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer KØBENHAVN, Danmark, 9. maj 2025 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse, hvilke hermed offentliggøres i overensstemmelse med §19 i Europa Parlamentets og Rådets forordning (EU) nr. 596/2014 samt Kommissionens Gennemførelsesforordning (EU) nr. 2016/523. Transaktionerne vedrør...

 PRESS RELEASE

Report of transactions of shares and related securities of Bavarian No...

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523. The tra...

 PRESS RELEASE

Bavarian Nordic offentliggør delårsregnskab for første kvartal 2025

Bavarian Nordic offentliggør delårsregnskab for første kvartal 2025 KØBENHAVN, Danmark, 9. maj 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab samt rapporterede på begivenheder for første kvartal 2025. Omsætningen i de første tre måneder sted med 62% til DKK 1.347 mio., hvilket afspejler en stærk udvikling i både Travel Health og Public Preparedness. Travel Health omsætning steg med 52% til DKK 680 mio. sammenlignet med første kvartal 2024, hvilket primært var drevet af øget efterspørgsel på vacciner mod rabies og flåtbåren hjernebetændelse (TBE).Public Preparedness...

 PRESS RELEASE

Bavarian Nordic Announces Interim Results for the First Three Months o...

Bavarian Nordic Announces Interim Results for the First Three Months of 2025 COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2025. Revenue for the first three months increased by 62% to DKK 1,347 million, reflecting a strong performance in both Travel Health and Public Preparedness. Travel Health revenue increased by 52% to DKK 680 million compared to the first quarter of 2024, primarily driven by increased demand for rabies and tick-borne encephalitis (TBE) vaccines.Public...

 PRESS RELEASE

Bavarian Nordic er blevet tildelt kontraktoptioner fra den amerikanske...

Bavarian Nordic er blevet tildelt kontraktoptioner fra den amerikanske regering til produktion og levering af frysetørret koppe- og mpoxvaccine Værdien af tildelte kontraktoptioner udgør USD 143.6 mio.Sikrer produktion og levering af frysetørret JYNNEOS® til USA i 2026 KØBENHAVN, Danmark, 6. maj 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Administration for Strategic Preparedness and Response (ASPR) ved U.S. Department of Health and Human Services (HHS) har udnyttet yderligere optioner til en værdi af...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch